Optiver Holding B.V. Cure Vac N.V. Transaction History

Optiver Holding B.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.5 - $10.77 $42,711 - $70,769	6,571 Added 2406.96%	6,844 $46,000
Q2 2023 Aug 10, 2023	BUY	$6.69 - $12.25 $755 - $1,384	113 Added 70.63%	273 $2,000
Q1 2023 May 11, 2023	BUY	$6.38 - $12.5 $1,020 - $2,000	160 New	160 $1,000
Q2 2022 Aug 10, 2022	SELL	$13.18 - $19.41 $1,041 - $1,533	-79 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $368 - $881	25 Added 46.3%	79 $2,000
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $573 - $819	17 Added 45.95%	54 $1,000
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $15,024 - $22,722	-305 Reduced 89.18%	37 $2,000
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $19,463 - $43,615	342 New	342 $25,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.